We are delighted to announce a significant recognition that underscores our commitment to #innovation and #sustainability! medmix Industry has been named a winner in the 2024 BIG Sustainability Awards, presented by the Business Intelligence Group, for its MIXPAC™ greenLine™ two-component cartridge systems. This recognition complements our recent success at the BIG Innovation Awards in January. Moving forward, our teams are inspired to accelerate our efforts in reducing CO2 emissions globally while developing sustainable solutions that meet the evolving needs of our customers. Learn more at https://lnkd.in/dYCcg_yk #productoftheyear #climateaction #sustainableimpact
medmix
Medizintechnik
Baar, Zug 23.477 Follower:innen
– medmix is a global leader in high-precision delivery devices across healthcare, consumer and industrial markets.
Info
medmix is a global leader in high-precision delivery devices. We occupy leading positions in the healthcare, consumer and industrial end-markets. Our customers benefit from a dedication to innovation and technological advancement that has resulted in over 900 active patents. Our 15 production sites worldwide together with our highly motivated and experienced team of over 1’900 employees provide our customers with uncompromising quality, proximity and agility. medmix is headquartered in Baar, Switzerland. Our shares are traded on the SIX Swiss Exchange (SIX: MEDX). www.medmix.swiss
- Website
-
http://medmix.swiss
Externer Link zu medmix
- Branche
- Medizintechnik
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Baar, Zug
- Kunst
- Kapitalgesellschaft (AG, GmbH, UG etc.)
Orte
-
Primär
Baar, Zug, CH
Beschäftigte von medmix
Aktualisierungen
-
Our half-year results are in. René Willi, CEO at medmix, shares “Having met our customers and dedicated teams in all market segments, geographies, and functions, I am convinced that we have all the elements of a global leader in high-precision delivery devices for the healthcare, consumer and industrial end-markets.” Highlights: - Year-on-year organic revenue decline primarily reflects phasing, with improved second half expected in four of five market segments - Improved gross profit margin, while lower volumes impact adjusted EBITDA margin - Increase in reported EBITDA, adjusted operating net cash flow and free cash flow - New ISO-certified Healthcare plant in Atlanta started production on schedule - New guidance: organic revenue growth flat to negative, adjusted EBITDA margin 18% to 19% Read our press release here: https://lnkd.in/gKQdkJRU Read our Half-year report here: https://lnkd.in/gY59Nvgn
-
“Customer-Centric Innovations” was the motto of our Innovation Day 2024, which took place at medmix Beauty Site in Bechhofen. It was an amazing day, filled with inspiring speeches, engaging discussions, and many creative ideas. Focusing on customer-centricity, the product teams from all business segments presented their latest innovations to our top management and seized the opportunity to collaborate and network with other innovators. Thank you to everyone who contributed to making this day a huge success and fostering our innovation culture at medmix! #innovation #inspiration #customers #leadership
-
-
We are excited to share that we have successfully completed the ISO 13485 audit for our new medmix Healthcare site in Atlanta. This facility is our new base for growth and scale for our Drug Delivery, Surgery and Dental segments. Reaching this significant milestone reflects our unwavering commitment to quality and excellence in medical device manufacturing. Achieving ISO 13485 certification ensures that our products consistently meet customer and regulatory requirements, enhancing patient safety and improving overall product performance. A big thank you to our dedicated team for their hard work and diligence in achieving this crucial certification. We look forward to continuing to provide innovative and reliable solutions to our customers. #Healthcare #Haselmeier #DrugDelivery #Surgery #Dental #ISO13485 #MedicalDevice
-
-
We are delighted to welcome René Willi as Chief Executive Officer of medmix! René brings a wealth of industry and leadership experience to power our company's future success. Our mission at medmix is to provide innovative solutions to help millions of people live healthier and more confident lives. Join us in welcoming René Willi as we start an exciting new chapter in our story. #Leadership #Innovation #HealthierLives
-
-
We are excited to announce that our legal team has been named "In-house team 2024 in healthcare, life sciences & pharma" at the Legalcommunity.ch. This esteemed recognition is a testament to our legal professionals' unwavering dedication, business mindset, and deep industry expertise. Embodying “Trust & Teamwork", one of our company values, they have been instrumental in navigating complex legal landscapes and providing strategic guidance to support the growth and success of our five business segments. We extend our heartfelt congratulations to each member of our legal team for this well-deserved recognition! For more information, please visit https://lnkd.in/dD4ueb2h #InHouseTeamOfTheYear #Healthcare #Legalcommunitych
-
-
We are pleased to report that all proposals of the Board have been approved by our shareholders at medmix' Annual General Meeting 2024. Moreover, we would like to thank all our shareholders for their continued support and commitment to our company! https://lnkd.in/dq6dCHej
-
-
Happy #EarthDay! While plastics play a significant role in every aspect of day-to-day life, at medmix, we continue to take actions that reduce its negative impact on our planet. In 2023, we launched 20 products based on post-consumer recycled and bio-based resins - actively reducing waste and supporting the circular economy. Learn more about our approach and progress in our Sustainability Review: https://lnkd.in/ddQuXvpQ #EarthDay #Sustainability #Innovation #CircularEconomy
-
-
We are pleased to announce a significant milestone for our organization. René Willi has been appointed as our new CEO, effective June 1, 2024. Read our press release here: https://lnkd.in/gi6A3JJr
-
-
Our Chief Legal Officer & Head of M&A, Xavier Schops, recently shared compelling insights at Université de Fribourg - Universität Freiburg lecturing Master students of the Institute for International Business Law - University of Fribourg on legal and practical aspects of #MergersAndAcquisitions. What an inspiring day, filled with engaging discussions and insightful queries!
Unlock M&A Success with Fribourg University's LLM Programs! 🌟 Embark on a transformative journey through the realm of mergers and acquisitions (M&A) at Fribourg University's Institute for International Business Law! Recently, our students experienced an immersive and interactive session, gaining firsthand insights into the dynamic world of M&A. Leveraging Xavier Schops substantial M&A experience, our lecture allows you to navigate through complex case studies and real-world scenarios, providing invaluable wisdom honed from years of global experience in the field of corporate transactions. From strategic negotiations to legal intricacies, Xavier's expertise ensures a comprehensive learning experience like no other. Ready to take your career to new heights? Join our vibrant community of learners and unlock the door to limitless opportunities with our LLM master programs. Be part of our dynamic journey! #MergersAndAcquisitions #LLM #FribourgUniversity #XavierSchops #Expertise #InteractiveLearning #JoinUs
-